Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study
CONCLUSION: DDR1 is aberrantly expressed in liposarcoma, and it contributes to several markers of oncogenesis in these tumors.CLINICAL RELEVANCE: This work supports DDR1 as a promising therapeutic target in liposarcoma.PMID:37768856 | DOI:10.1097/CORR.0000000000002865
Source: Clinical Orthopaedics and Related Research - Category: Orthopaedics Authors: Dylan C Dean Wenlong Feng Robert L Walker Pichaya Thanindratarn H Thomas Temple Jonathan C Trent Andrew E Rosenberg Francis J Hornicek Zhenfeng Duan Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Lipoma | Liposarcoma | Neurology | Orthopaedics | Sarcomas | Soft Tissue Sarcoma | Study | Toxicology